Agenus Inc (NAS:AGEN)
$ 14.56 0.99 (7.3%) Market Cap: 305.75 Mil Enterprise Value: 341.77 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Agenus Inc. - Special Call Transcript

Nov 15, 2019 / 04:00PM GMT
Release Date Price: $73.01 (-0.53%)
Garo H. Armen
Agenus Inc. - Founder, Executive Chairman & CEO

I think we have a full house, and we are ready to start. Thank you very much for attending this session. The last time we had an R&D Day was in May of 2015. And as you'll see today, there's a lot that has happened. In 2015, we were transitioning into a fully burdened, if you will, what's called now an immuno-oncology company. And what I'll start with is, of course, the disclaimers, which I need not elaborate on what this means. It's the hypocrisy of the system that can say we can lie all we want and you can't sue us. That's what this statement says, unfortunately.

Unidentified Company Representative

(inaudible)

Garo H. Armen
Agenus Inc. - Founder, Executive Chairman & CEO

That's right. I'm Garo Armen. I founded the company 25 years ago. And we have been in the business of immunology of cancer for the last 25 years. We have a very exciting program today. Some very distinguished guests that are under the ice. Heads of different cancer centers and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot